Durvalumab

SEP 9, 2026 · PHASE 2 TRIAL

A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy

ClinicalTrials.gov

This is a Phase 2 trial registry record with no results posted; enrollment is complete but outcomes have not yet been reported or analysed.

SEP 8, 2026 · PHASE 3 TRIAL

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

ClinicalTrials.gov

This is a Phase 3 clinical trial registry record with no reported results; the study is active but not recruiting, and efficacy outcomes have not yet been posted.

SEP 8, 2026 · PHASE 3 TRIAL

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

ClinicalTrials.gov

This is a registered Phase 3 trial currently recruiting with no results posted; it describes a planned comparison but carries no outcome data.

SEP 4, 2026 · PHASE 2 TRIAL

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 trial registration with no results posted; it describes a planned interventional study testing TRC102 added to chemoradiotherapy in stage III NSCLC, designed to assess feasibility and signal before larger trials.

AUG 20, 2026 · PHASE 3 TRIAL

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ClinicalTrials.gov

This is a Phase 3 trial registration with no reported results; the study is actively recruiting and outcome data are not yet available.

AUG 13, 2026 · PHASE 3 TRIAL

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

ClinicalTrials.gov

This is a Phase 3 trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for analysis.

AUG 12, 2026 · PHASE 2 TRIAL

Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with no results posted; it describes a planned study of personalized immunotherapy selection based on MRD detection in stage III NSCLC, addressing an important clinical question but carrying no outcome data.

AUG 11, 2026 · PHASE 3 TRIAL

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no reported results; the study is active but not yet recruiting and outcome data are not posted in this registry record.